Group 1: Financial Performance - In 2024, the company achieved operating revenue of 199,120.04 million yuan, representing a year-on-year growth of 1.07% [2] - The net profit attributable to shareholders was 18,304.60 million yuan, with a year-on-year increase of 3.26% [2] Group 2: Growth Drivers - The company aims to deepen the integration of AI cognitive technology and multi-modal BioCV core technology to enhance product intelligence, user experience, and operational efficiency [2] - A multi-brand strategy will be implemented, operating under four brands: "ZKTeco", "ZKDIGIMAX", "NGTeco", and "Armatura" [2] - The company will continue to expand its global operations, focusing on both breadth and depth of business [2] Group 3: Product Development - The company is focusing on three core application scenarios for brain-machine technology: education, healthcare, and elderly care, utilizing AI-driven multi-modal data fusion technology [1] - Key products include the ZALO multi-dimensional perception terminal, Ralvie AI smart office assistant, and RS multi-dimensional edge AI server [1] Group 4: M&A Strategy - The company emphasizes organic growth but will consider external acquisition opportunities that align with its business needs and synergies [1]
熵基科技(301330) - 301330熵基科技投资者关系管理信息20250430